8 July 2019 in Nature Microbiology
Microbiomes are vast communities of microorganisms and viruses that populate all natural ecosystems. Viruses have been considered to be the most variable component of microbiomes, as supported by virome surveys and examples of high genomic mosaicism. However, recent evidence suggests that the human gut virome is remarkably stable compared with that of other environments. Here, we investigate the origin, evolution and epidemiology of crAssphage, a widespread human gut virus. Through a global collaboration, we obtained DNA sequences of crAssphage from more than one-third of the world’s countries and showed that the phylogeography of crAssphage is locally clustered within countries, cities and individuals. We also found fully colinear crAssphage-like genomes in both Old-World and New-World primates, suggesting that the association of crAssphage with primates may be millions of years old. Finally, by exploiting a large cohort of more than 1,000 individuals, we tested whether crAssphage is associated with bacterial taxonomic groups of the gut microbiome, diverse human health parameters and a wide range of dietary factors. We identified strong correlations with different clades of bacteria that are related to Bacteroidetes and weak associations with several diet categories, but no significant association with health or disease. We conclude that crAssphage is a benign cosmopolitan virus that may have coevolved with the human lineage and is an integral part of the normal human gut virome.
1 June 2011 in Pediatric Obesity
Objective: Trends of overweight (ov)/obesity (ob) prevalence among German children aged 4–16 years were studied between 1999 and 2008. Subjects: Body mass index (BMI) data (>P90 [ov] and >P97 [ob]) from the national CrescNet database were analysed in three age groups: 4–7.99, 8–11.99, and 12–16 years. Results. Trend analyses. Data from 272 826 children were analyzed. a) Whole study population aged 4–16 years old. A significant upward trend for ov/ob prevalence was found between 1999 and 2003, and a significant downward trend between 2004 and 2008. b) Subgroup analyses. Ov/Ob prevalence increased in most subgroups studied until 2004. Between 2004 and 2008, a downward trend for ov/ob prevalence was found in children, aged 4–7.99 years, whereas it stabilized in most other subgroups studied. Cross-sectional analyses. Data from 93 028 children were analyzed. Ov/ob prevalence was significantly higher in 2004 compared with 2000 in girls aged 12–16 years and in boys aged 8–16 years. Ov/ob obesity prevalence was significantly lower in 2008 compared with 2004 in children aged 4–7.99 years. Conclusion. Ov/ob prevalence increased between 1999 and 2003 in German children. Since 2004, this trend has been stabilizing or turning into a downward trend. Our data confirm the global trend of stabilizing prevalence rates of childhood obesity at a high level and add important information for individual age groups. Intervention programs targeted to prevent childhood obesity may have had beneficial effects, and a new balance between factors favouring obesity and those favouring leanness may have been reached recently. Age- and gender-specific differences found in trends of ov/ob prevalence may help optimise preventive and therapeutic measures.
1 March 2010 in The Journal of Clinical Endocrinology & Metabolism
Background: IGF-I receptor (IGF1R) plays an essential role in human intrauterine and postnatal development. Few heterozygous mutations in IGF1R leading to IGF-I resistance and intrauterine and postnatal growth retardation have been described to date. Objective: The clinical and functional relevance of a novel heterozygous IGF1R mutation identified in a girl with short stature and six relatives was evaluated. Patients: Affected individuals showed birth lengths between −1.40 and −1.82 sd score (SDS) and birth weights between −1.84 and −2.19 SDS. Postnatal growth retardation ranged between −1.51 and −3.93 height SDS. Additional phenotypic findings were variable including microcephaly, clinodactyly, delayed menarche, and diabetes mellitus type 2. Genetic analyses were initiated due to elevated IGF-I levels of the girl. Results: Denaturing HPLC screening and direct DNA sequencing revealed a heterozygous G3464C IGF1R mutation in exon 19 located within a phylogenetically conserved motif of the kinase domain. The resultant mutation of glycine 1125 to alanine (G1125A) did not affect IGF1R protein expression in transiently transfected COS-7 cells and Igf1R deficient mouse fibroblasts but abrogated IGF-I-induced receptor autophosphorylation and phosphorylation of downstream kinases protein kinase B/Akt and MAPK/Erk (mouse proteins are reported). Cotransfection of wild-type and mutant IGF1R resulted in reduced autophosphorylation of 36 ± 10% of wild-type levels, suggesting a partial dominant-negative effect. Conclusion: The identified G1125A mutation results in a kinase-deficient IGF1R, which is likely to cause the phenotype of intrauterine and postnatal growth retardation.
1 October 2020 in Diabetes Research and Clinical Practice
17 June 2019 in Pediatrics International
1 October 2018 in Diabetes Research and Clinical Practice